Karakteristik Pasien Tumor Orbita Di PMN RS Mata Cicendo Bandung Periode 2017-2018

Authors

  • Ira Citra Ningrom Faculty of Medicine , Muhammadiyah Purwokerto University
  • Andi Muh. Maulana Faculty of Medicine , Muhammadiyah Purwokerto University
  • Susiyadi Susiyadi <p>Faculty of Medicine , Muhammadiyah Purwokerto University</p><p> </p>
  • Raudatul Janah Cicendo Bandung National Eye Center

DOI:

https://doi.org/10.30595/hmj.v4i2.10380

Keywords:

orbital tumor, characteristics, cicendo eye hospital

Abstract

Orbital tumors are tumors that occur in the orbital area where they can affect the outside of the orbit and the inside of the orbit. At present, it is still rare to report the prevalence of orbital tumors in the world. In developing countries such as Indonesia, reports on the incidence of orbital tumors are also rarely reported. Diagnosis and appropriate therapy if we recognize the characteristics of these orbital tumors. The purpose of this study was to determine the characteristics of orbital tumor patients at PMN Cicendo Eye Hospital Bandung. This research is a descriptive observational study with cross sectional method with total sampling technique. Data were collected retrospectively based on medical records in the form of age, sex, eyes involved, tumor location, surgery, clinical diagnosis, and histopathological results. The results showed that orbital tumors with the majority of age> 45 years (43.3%), male gender (55.4%), involvement of the left ocular eye (51.18%), with the most frequent location not in the conjunctiva, palpebral and retrobulbar (36.8%), clinical diagnosis of benign tumors (68.3%) were cysts (22.4%), the most histopathological results of benign tumor lesions (71.4%) were inflammation (17%). So it can be concluded that knowing the characteristics of this orbital tumor will have an impact on the therapy given will be appropriate.

Author Biographies

Ira Citra Ningrom, Faculty of Medicine , Muhammadiyah Purwokerto University

Pathology Anatomi

Andi Muh. Maulana, Faculty of Medicine , Muhammadiyah Purwokerto University

anatomy and histology

Susiyadi Susiyadi, <p>Faculty of Medicine , Muhammadiyah Purwokerto University</p><p> </p>

anestesiologi

Raudatul Janah, Cicendo Bandung National Eye Center

Patologi Anatomik

References

  1. Soebagdjo, H.D. Onkologi Mata/Hendrian D. Soebagjo. -- Surabaya: Airlangga University Press, 2019.
  2. Amemiya T., Hayashida H., and Dake Y. 2002. Metastatic orbital tumors in Japan: A review of the literature. Ophthalmic Epidemiology. 9(1); 35-47. DOI: 10. 1076/opep. 9. 1. 35. 1718.
  3. Bonham, J., Ginat, D. T., & Freitag, S. K. (2015). Imaging after orbital and intraocular oncology therapies. In Post-Treatment Imaging of the Orbit. https://doi.org/10.1007/978-3-662-44023-0_8
  4. Course, C. S. (2015). Basic and Clinical Science Course. In American Academy of Ophthalmology.
  5. Setia, M. (2016). Methodology series module 3: Cross-sectional studies. Indian Journal of Dermatology, 61(3), 261. https://doi.org/10.4103/0019-5154.182410
  6. Sopiyudin Dahlan, M. (2016). Besar Sampel dalam Penelitian Kedokteran dan Kesehatan. In Epidemiologi Medika.
  7. American Cancer Society. 2018. Cancer Facts & Figures 2018. Atlanta. p. 1-76. Website: https://www.cancer.org/content/dam/cancer- org/research/ cancer-facts-and-statistics/annual- cancer-facts-and-figures/2018/ cancer-facts-and-fi gures-2018.
  8. Cancer Research UK. 2015. Eye Cancer Incidence Statistics. https://www.cancerresearchuk. org/health-professional/cancer-statistics/statistics- bycancer-type/eye-cancer/incidence#heading.
  9. aspiration cytology. Journal of Cytology 2008:25; 133-137
  10. Eldesouky, M. A., & Elbakary, M. A. (2015). Clinical and imaging characteristics of orbital metastatic lesions among egyptian patients. Clinical Ophthalmology. https://doi.org/10.2147/OPTH.S87788
  11. Tailor, T. D., Gupta, D., Dalley, R. W., Dirk Keene, C., & Anza, Y. (2013). Orbital neoplasms in adults: Clinical, radiologic, and pathologic review. Radiographics.
  12. Kumar M Santosh. Cytohistological study of eyelid lesions and pitfalls in fine needle
  13. Wang J-K, Liao S-L, et al. Malignant eyelid tumours in Taiwan. Eye 2003;17: 216-220 https://doi.org/10.1148/rg.336135502
  14. Olsen, T. G., & Heegaard, S. (2019). Orbital lymphoma. Survey of Ophthalmology. https://doi.org/10.1016/j.survophthal.2018.08.002
  15. Khan, S. N., & Sepahdari, A. R. (2012). Orbital masses: CT and MRI of common vascular lesions, benign tumors, and malignancies. Saudi Journal of Ophthalmology. https://doi.org/10.1016/j.sjopt.2012.08.001
  16. Ushalatha B dan Sambasivarao. 2016 Role of CT in the Evaluation of Orbital Tumors. IOSR-JDMS. 15(4):16-19

Downloads

Published

2021-05-02

Issue

Vol. 4 No. 2 (2021): Herb-Medicine Journal April 2021

Section

Research Articles

License

For submission of manuscripts to the Herb-Medicine Journal, the authors must certify that:

I have been authorized by my co-author to submit the manuscript to the Herb-Medicine Journal
I hereby declare, on behalf of myself and my co-authors, that:

The submitted manuscript is original work and has not been published in another peer-reviewed journal or is being considered for publication by another journal. Also, the manuscript does not infringe any existing copyright or other third party rights.
The manuscript does not contain material that may violate the law, slander, or SARA, in any way, violates the terms and conditions contained in the agreement
I/we have taken care that the scientific knowledge and all other statements contained in the manuscript are in accordance with authentic facts and formulas and will not, if followed appropriately, harm the user
No liability shall be assumed by Herb-Medicine Journal, its staff or members of the editorial board for any injury and/or damage to persons or property as a matter of product liability, negligence or otherwise, or from the use or operation of any method, product instructions, advertising , or ideas contained in publications by the Herb-Medicine Journal

Authors who publish in the Herb-Medicine Journal certify that all authors have read and agree to the contents of the Cover Letter or the Terms and Conditions. Plagiarism is strictly prohibited, and by submitting a manuscript for publication, the author agrees that the publisher has the legal right to take appropriate action against the author, if plagiarism or false information is found. Once submitted to the Herb-Medicine Journal, authors will not withdraw their manuscript at any stage prior to publication.

The author owns the copyright and grants the journal rights for first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows others to share the work with acknowledgment of the work's authorship and initial publication in this journal.

Authors may enter into separate additional contractual agreements for the non-exclusive distribution of the published journal version of the work (for example, posting it to an institutional repository or publishing it in a book), with acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their websites) prior to and during the submission process, as this can lead to productive exchanges, as well as earlier and larger citation of published work (See The Effects of Open Access).

Untuk pengiriman naskah ke Herb-Medicine Journal, penulis harus menyatakan bahwa:

  1. Saya telah diberikan otorisasi oleh rekan penulis saya untuk memasukkan naskah ke Herb-Medicine Journal
  2. Saya dengan ini menyatakan, atas nama saya dan rekan penulis saya, bahwa:
  • Naskah yang dikirimkan adalah karya asli dan belum pernah diterbitkan dalam jurnal peer-review lain atau sedang dipertimbangkan untuk diterbitkan oleh jurnal lain. Serta, naskah tidak melanggar hak cipta yang ada atau hak pihak ketiga lainnya.
  • Naskah tidak mengandung materi yang mungkin melanggar hukum, memfitnah, atau SARA, dengan cara apa pun, melanggar syarat dan ketentuan yang tercantum dalam perjanjian
  • Saya / kami telah berhati-hati bahwa pengetahuan ilmiah dan semua pernyataan lain yang terkandung dalam naskah sesuai dengan fakta dan formula otentik dan tidak akan, jika diikuti dengan tepat, merugikan pengguna
  • Tidak ada tanggung jawab yang ditanggung oleh Herb-Medicine Journal, stafnya atau anggota dewan editorial untuk setiap cedera dan/atau kerusakan pada orang atau properti sebagai masalah pertanggungjawaban produk, kelalaian atau sebaliknya, atau dari penggunaan atau pengoperasian metode, produk apa pun instruksi, iklan, atau ide yang terkandung dalam publikasi oleh Herb-Medicine Journal

Penulis yang menerbitkan dalam Herb-Medicine Journal menyatakan bahwa semua penulis telah membaca dan menyetujui isi Surat Pengantar atau Syarat dan Ketentuan. Plagiarisme dilarang keras, dan dengan menyerahkan naskah untuk publikasi, penulis setuju bahwa penerbit memiliki hak hukum untuk mengambil tindakan yang pantas terhadap penulis, jika ditemukan plagiarisme atau informasi palsu. Setelah diserahkan ke Herb-Medicine Journal, penulis tidak akan menarik naskah mereka pada tahap apa pun sebelum dipublikasikan.

Penulis memiliki hak cipta dan memberikan hak jurnal untuk publikasi pertama dengan karya yang secara simultan dilisensikan di bawah Lisensi Creative Commons Attribution yang memungkinkan orang lain untuk berbagi karya dengan pengakuan kepengarangan karya dan publikasi awal dalam jurnal ini.

Penulis dapat membuat perjanjian kontrak tambahan yang terpisah untuk distribusi non-eksklusif versi jurnal yang diterbitkan dari karya tersebut (misalnya, mempostingnya ke repositori institusional atau menerbitkannya dalam sebuah buku), dengan pengakuan atas publikasi awalnya di jurnal ini.

Penulis diizinkan dan didorong untuk memposting pekerjaan mereka secara online (misalnya, dalam repositori institusional atau di situs web mereka) sebelum dan selama proses pengajuan, karena dapat menyebabkan pertukaran yang produktif, serta kutipan yang lebih awal dan lebih besar dari karya yang diterbitkan (Lihat The Effect of Open Access).